We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Research Article

On enhancers and inhibitors of elastin-derived amyloidogenesis

    Brigida Bochicchio

    University of Basilicata, Department of Chemistry, Via N. Sauro 85, 85100 Potenza, Italy.

    ,
    Marina Lorusso

    University of Basilicata, Department of Chemistry, Via N. Sauro 85, 85100 Potenza, Italy.

    ,
    Antonietta Pepe

    University of Basilicata, Department of Chemistry, Via N. Sauro 85, 85100 Potenza, Italy.

    &
    Antonio Mario Tamburro

    † Author for correspondence

    University of Basilicata, Department of Chemistry, Via N. Sauro 85, 85100 Potenza, Italy.

    Published Online:https://doi.org/10.2217/17435889.4.1.31

    Aims: The main aim of this study is to better understand the self-aggregation mechanism of amyloid-like elastin-derived fibers in order to design and produce new powerful drugs that will inhibit the onset of ‘amyloidosis’. Materials & methods: Atomic force microscopy (AFM), Congo Red birefringence assay and Thioflavin T fluorescence measurements were used to demonstrate the amyloid-like behavior of some fragments of elastin protein (exon 30 [EX30] and exon 28 [EX28]). Turbidimetry on apparent absorbance technique was used to investigate the effect either of enhancers or of inhibitors on the amyloidogenic elastin-like peptides. Circular-dichroism spectroscopy was used to study the secondary structures of the peptides. Results & discussion: We used Congo Red birefringence assay, Thioflavin T fluorescence measurements and AFM measurements that are used commonly to demonstrate the formation of amyloids. The elastin fibrillogenesis is amyloid-like. Then, the elastin amyloidogenesis is inhibited by particular pentapeptides. Conclusions: We have reported herein that the fibrillogenesis of elastin-derived EX28 and EX30 polypeptides is facilitated significantly by the effect of sodium taurocholate bile salt and is inhibited by a classical inhibitor of Aβ-amyloid peptide, such as KLVFF, as well as by novel inhibitors, designed by us on the basis of some elastin sequences.

    Bibliography

    • Bochicchio B, Pepe A, Flamia R, Lorusso M, Tamburro AM: Investigating the amyloidogenic nanostructured sequences of elastin: sequence encoded by exon 28 of human tropoelastin gene. Biomacromolecules8(11),3478–3486 (2007).
    • Tamburro AM, Pepe A, Bochicchio B, Quaglino D, Ronchetti IP: Supramolecular amyloid-like assembly of the polypeptide sequence coded by exon 30 of human tropoelastin. J. Biol. Chem.280(4),2682–2690 (2005).
    • Bochicchio B, Pepe A, Tamburro AM: Elastic fibers and amyloid deposition in vascular tissue. Future Neurol.2,523–536 (2007).
    • Ostuni A, Bochicchio B, Armentano MF, Bisaccia F, Tamburro AM: Molecular and supramolecular structural studies on human tropoelastin sequences. Biophys. J.93(10),3640–3651 (2007).
    • Flamia R, Lanza G, Salvi AM, Castle JE, Tamburro AM: Conformational study and hydrogen bonds detection on elastin-related polypeptides using X-ray photoelectron spectroscopy. Biomacromolecules6(3),1299–1309 (2005).
    • Flamia R, Salvi AM, D’Alessio L, Castle JE, Tamburro AM: Transformation of amyloid-like fibers, formed from an elastin-based biopolymer, into a hydrogel: an X-ray photoelectron spectroscopy and atomic force microscopy study. Biomacromolecules8(1),128–138 (2007).
    • Flamia R, Zhdan PA, Martino M, Castle JE, Tamburro AM: AFM study of the elastin-like biopolymer poly(ValGlyGlyValGly). Biomacromolecules5(4),1511–1518 (2004).
    • Del Mercato LL, Pompa PP, Maruccio G et al.: Charge transport and intrinsic fluorescence in amyloid-like fibrils. Proc. Natl Acad. Sci. USA104(46),18019–18024 (2007).
    • Pepe A, Guerra D, Bochicchio B et al.: Dissection of human tropoelastin: supramolecular organization of polypeptide sequences coded by particular exons. Matrix Biol.24(2),96–109 (2005).
    • 10  Tamburro AM, Bochicchio B, Pepe A: Dissection of human tropoelastin: exon- by-exon chemical synthesis and related conformational studies. Biochemistry42(45),13347–13362 (2003).
    • 11  Guantieri V, Tamburro AM, Gordini DD: Interactions of human and bovine elastins with lipids: their proteolysis by elastase. Connect. Tissue Res.12(1),79–83 (1983).
    • 12  Getie M, Schmelzer CE, Neubert RH: Characterization of peptides resulting from digestion of human skin elastin with elastase. Proteins61(3),649–657 (2005).
    • 13  Mattson MP, Cheng B, Davis D et al.: β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci.12(2),376–389 (1992).
    • 14  Gestwicki JE, Crabtree GR, Graef IA: Harnessing chaperones to generate small-molecule inhibitors of amyloid-β aggregation. Science306(5697),865–869 (2004).
    • 15  Necula M, Kayed R, Milton S, Glabe CG: Small molecule inhibitors of aggregation indicate that amyloid-β oligomerization and fibrillization pathways are independent and distinct. J. Biol. Chem.282(14),10311–10324 (2007).
    • 16  D’Ursi AM, Armenante MR, Guerrini R et al.: Solution structure of amyloid-β-peptide (25–35) in different media. J. Med. Chem.47(17),4231–4238 (2004).
    • 17  Tjernberg LO, Naslund J, Lindqvist F et al.: Arrest of β-amyloid fibril formation by a pentapeptide ligand. J. Biol. Chem.271(15),8545–8548 (1996).
    • 18  Luo Y, Smith JV, Paramasivam V et al.: Inhibition of amyloid-β aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc. Natl Acad. Sci. USA99(19),12197–12202 (2002).
    • 19  Wu Y, Wu Z, Butko P et al.: Amyloid-β-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J. Neurosci.2613102–13113 (2006).
    • 20  Nakanishi K: Terpene trilactones from Gingko biloba: from ancient times to the 21st century. Bioorg. Med. Chem.13(17),4987–5000 (2005).
    • 21  van Beek TA: Ginkgolides and bilobalide: their physical, chromatographic and spectroscopic properties. Bioorg. Med. Chem.13(17),5001–5012 (2005).
    • 22  Bochicchio B, Tamburro AM: Polyproline II structure in proteins: identification by chiroptical spectroscopies, stability, and functions. Chirality14(10),782–792 (2002).
    • 23  Geddes AJ, Parker KD, Atkins ED, Beighton E: “Cross-β” conformation in proteins. J. Mol. Biol.32(2),343–358 (1968).
    • 24  Jimenez JL, Nettleton EJ, Bouchard M et al.: The protofilament structure of insulin amyloid fibrils. Proc. Natl Acad. Sci. USA99(14),9196–9201 (2002).
    • 25  Eanes ED, Glenner GG: X-ray diffraction studies on amyloid filaments. J. Histochem. Cytochem.16(11),673–677 (1968).
    • 26  Roccatano D, Colombo G, Fioroni M, Mark AE: Mechanism by which 2,2,2-trifluoroethanol/water mixtures stabilize secondary-structure formation in peptides: a molecular dynamics study. Proc. Natl Acad. Sci. USA99(19),12179–12184 (2002).
    • 27  Koldamova R, Staufenbiel M, Lefterov I: Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J. Biol. Chem.280(52),43224–43235 (2005).
    • 28  Coisne D, Corbi P, Sosner P: Obstructive intramural coronary amyloidosis and papillary muscle rupture. Heart89(2),E8 (2003).
    • 29  Dookstam S, Bohl JRE, Sahraian A, Mahjoor AA: Amyloid deposits in senile vertebral arteries, immunohistological and ultrastructural findings. Pak. J. Biol. Sci.11(14),1852–1855 (2008).
    • 30  Soto C, Kindy MS, Baumann M, Frangione B: Inhibition of Alzheimer’s amyloidosis by peptides that prevent β-sheet conformation. Biochem. Biophys. Res. Commun.226(3),672–680 (1996).